Unpack ACC.25's Top Trials with View from the Thoraxcenter!
Join Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC, Rotterdam for a deep dive into the late-breaking data presented at ACC 2025.
In this thought-provoking ACC 2025 wrap-up, delve into the nuances of the most impactful trials, gaining insights into their implications for current practice and future research directions.
00:36 - BHF PROTECT TAVI
06:07 - EVOLUT Low Risk
09:17 - TRILUMINATE Pivotal
13:56 - FAME 3
17:50 - ECLIPSE
20:43 - ALTSHOCK II
28:18 - SMART CHOICE 3
31:52 - EKSTROM
34:53 - DAPA TAVI
37:25 - FAIR-HF 2
For more content from ACC 2025 head to the Late-breaking Science Video Collection.
Comments